Trinity Biotech ADR buy StockNews.com
Start price
24.11.23
/
50%
€0.36
Target price
24.11.24
-
Performance (%)
13.81%
Price
22.02.24
€0.41
Summary
This prediction is currently active. The BUY prediction by StockNews_com currently has a performance of 13.81%. This prediction currently runs until 24.11.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Trinity Biotech ADR | - | - |
iShares Core DAX® | -0.372% | 5.236% |
iShares Nasdaq 100 | -1.950% | 1.680% |
iShares Nikkei 225® | -1.690% | 7.286% |
iShares S&P 500 | -0.399% | 2.379% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat